Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03355976
Title BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Don Dizon
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois Chicago Chicago Illinois 60612 United States Details
Rhode Island Hospital Providence Rhode Island 02903 United States Details
Women & Infants Hospital Providence Rhode Island 02905 United States Details
The Miriam Hospital Providence Rhode Island 02906 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field